|
HS Code |
765908 |
As an accredited 4-Bromo-2,3-Difluorobenzoic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Bromo-2,3-Difluorobenzoic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemists in pharmaceuticals and advanced material development see plenty of compounds come and go. Some, like 4-Bromo-2,3-Difluorobenzoic Acid, keep coming back because of their unmistakable value in synthesis work. This isn’t just another benzoic acid—its bromo and difluoro substitutions open up pathways for targeted molecule building that push beyond what ordinary benzoic acids offer.
Anyone who’s put together synthetic routes in a research lab knows subtle changes on a benzene ring can make the difference between an effective reaction and a series of failed work-ups. 4-Bromo-2,3-Difluorobenzoic Acid, with its bromo group at the fourth position and fluorines at the second and third, belongs in the toolkit because its electronic profile responds differently under various reaction conditions. Substituents like fluorine pull electron density away, while the bromo group in the para position allows for versatile coupling reactions. This unique arrangement lets researchers chase targets that demand both reactivity and selectivity, especially in medicinal and materials chemistry.
The molecular formula weighs in at C7H3BrF2O2, and a closer look at the structure reveals how the bromine and the two fluorines transform the classic benzoic acid framework. Fluorines on adjacent carbons add rigidity and introduce steric effects that can block certain reactive sites while activating others. The bromo group, known for good leaving group behavior, supports Suzuki-Miyaura and similar cross-couplings. This selectivity is valuable for crafting compounds that display increased metabolic stability in drug candidates or tailored electronic properties in organic electronic components. It strikes a balance between interesting reactivity and dependable handling for those who see plenty of chemicals pass through their hands.
Most suppliers who provide 4-Bromo-2,3-Difluorobenzoic Acid aim for analytically verified purity above 97%, as even small contaminants can throw off yields in sensitive coupling reactions or lead to headaches during purification. The acid typically forms a white to off-white solid, with melting points and solubility profiles matching expectations for substituted benzoic acids. This consistency allows synthetic chemists to focus resources on building their target molecules rather than troubleshooting starting materials.
No two organic synthesis routes are quite the same. I’ve run plenty of reactions where the choice of a bromo- over an iodo- or chloro-substituent set the whole tone for the workup. With 4-Bromo-2,3-Difluorobenzoic Acid, the combination of strong carbon-halogen and carbon-fluorine bonds supports cross-coupling and nucleophilic substitution while improving downstream stability. Researchers lean on this compound for accessing multi-substituted aromatics or as an intermediate in synthesizing active pharmaceutical ingredients, especially those benefiting from enhanced metabolic resistance—a property often introduced by fluorine atoms.
Its acid function gives room for further transformations: esterification to prepare prodrugs, amidation for peptide linkage, or salification to improve handling and solubility profiles. In my own experience, being able to shift quickly between these derivatizations helps shorten project timelines and keeps costs down, especially for milligram-to-gram-scale library synthesis. On the industrial scale, the same properties make pilot plant conversions more predictable, minimizing yield losses and the need for repeated purification cycles.
Dalton’s experiments with elemental bromine and the discovery of fluorine’s remarkable electronegativity didn’t just fill out periodic tables; chemists since then have learned that the behavior of these elements on aromatic systems can unlock new chemical spaces altogether. In drug discovery, introducing fluorine atoms often helps metabolic stability, increases binding affinity, and sometimes improves the overall physicochemical profile of a lead molecule. Bromine substituents allow efficient cross-coupling—a workhorse method in medicinal and material chemistry labs.
So, with both elements in play, 4-Bromo-2,3-Difluorobenzoic Acid is more than just raw material; it becomes a launching pad for medicinal chemists looking to tweak receptor affinity or for material scientists chasing new OLED emitters or insulators. Allowing such adjustments early in the synthetic process gives a flexibility that less-substituted benzoic acids just can’t match.
Some might ask, why not just use the single-substituted or unsubstituted compounds, or swap for a different benzoic acid derivative? It’s a fair question for cost-control and project planning. The two fluorines here accomplish several goals: they enhance resistance to metabolic oxidation, impact boiling and melting points, and modify partition coefficients in ways that can benefit drug absorption and stability. The bromo group allows fast, high-yielding coupling with aryl or vinyl boronic acids, expanding the accessible chemical space with established, scalable procedures.
Compare this to a mono-bromo or mono-fluoro benzoic acid, and you’ll find fewer options for medicinal or material design. Mono-substituted versions may not block undesired metabolic sites as effectively, may lead to less stable or less selective derivatives, or simply close off possible downstream syntheses that require those particular electronic properties for success. Labs and companies doing early-stage research have learned from experience the time cost of using a less versatile starting point, only to revisit projects later when more advanced, multi-substituted intermediates become available.
In research settings, I’ve watched teams switch to 4-Bromo-2,3-Difluorobenzoic Acid to shave days—and sometimes weeks—off their synthetic campaigns. Synthesis of complex molecules becomes streamlined, with the possibility to branch out at any step. In drug discovery, this flexibility translates to faster SAR (structure-activity relationship) exploration, as you can append varied groups at the bromine position through palladium-catalyzed coupling in one step. In electronics, the combined fluorine effect imparts desirable changes in charge mobility and thermal stability—there’s a reason why device chemists prize such structures for developing next-generation organic semiconductors.
The acid group, while nothing new to organic chemists, plays a stubbornly important role. Its reactivity grants options for coupling to linkers, polymer backbones, or even short peptide sequences for advanced probe molecules. It’s hard to overstate how much a small, predictable carboxylic acid can open up workflow efficiency—hooking to a resin for solid-phase synthesis, moving to esters for prodrug efforts, or turning into amides for backbone modifications in medicinal chemistry.
Some organic intermediates wear out their welcome with constant degradation or unpredictable reactivity, but 4-Bromo-2,3-Difluorobenzoic Acid, thanks to those two fluorines, holds up well under regular lab storage. Good practice—keeping it sealed, dry, and away from sunlight—avoids unwanted hydrolysis or decomposition. Its thermal stability allows for safe handling, and it weighs in as a manageable, non-volatile solid at room temperature. For context, more reactive benzoic acid derivatives sometimes need refrigeration or inert atmosphere just to survive the workday—here, standard storage keeps life simple.
In scaling up reactions, the reliable physicochemical properties limit surprises. Reactions involving it don’t present mystery exotherms, and the product persists through standard workups. My own time working with similar compounds has shown that you can run parallel syntheses with high confidence in batch-to-batch consistency—a small mercy when chasing deadlines or scaling for larger preclinical runs.
Transparency and trust matter in modern research just as much as the quality of reagents. Open lab notebooks and auditable supply chains win over procurement and regulatory teams, especially when compounds like 4-Bromo-2,3-Difluorobenzoic Acid play roles in regulated environments such as clinical candidate manufacture. Suppliers with robust Certificates of Analysis and accessible analytical data (NMR, HPLC, MS) help build confidence downstream. As someone who’s submitted form after form to quality and compliance teams, seeing consistent, verifiable product documentation saves time and avoids costly retesting.
E-E-A-T standards—Experience, Expertise, Authoritativeness, Trustworthiness—frame not only how we approach chemical intermediates but also how we report and interpret data from their use. The record shows that trusted sources lead to fewer failed experiments and better, quicker product progression in competitive research environments. Bringing this awareness to daily lab work has always set high-performing teams apart from the rest.
Every synthetic route presents its own surprises, and not all intermediates behave as textbooks predict. The bromo group on this acid lends itself to cross-coupling, yet carelessness with activating agents or reaction conditions can trigger side reactions or over-reduction. In such cases, using proven ligands or fine-tuning catalyst loading avoids waste and improves reliability. Multiplicity of fluorines on the ring changes not just reactivity but also HPLC profiles, sometimes complicating analytical separation from close analogs. Running extra columns or applying method development can head off issues in purification and analysis.
Scale-up is where real-world differences stand out. What works for fifty milligrams in a hood sometimes falls short at the kilogram level. Reproducibility, monitored through in-line analysis or rigorous QC testing, keeps disappointments to a minimum. Looking back at both academic and startup industrial settings, simple controls like routine checks of raw material moisture content or implementing closed-system reactors have sidestepped major production bottlenecks.
Chemicals with halogen substitutions deserve a watchful eye. Safe handling and waste management policies are priorities in modern chemistry labs, as bromo- or fluoro- intermediates can give rise to persistent organic pollutants if mishandled. Experienced chemists know the regulations and most contemporary facilities are equipped to treat or recover halogenated wastes responsibly. Researchers comply not only due to law but also pride in sustainable bench work.
Personal protective equipment and careful ventilation minimize exposure risk—this mirrors my own routine of double-gloving and using chemical fume hoods when weighing or dosing similar acids. Standard operating procedures—never skipped, even in a rush—cut down on spills and accidental contamination. Proper labeling and documentation anchor accountability, which helps when audits or regulatory bodies check records for active R&D projects.
Demand for substituted benzoic acids with dual halogens has grown with the advance of targeted therapies and next-gen organic materials. Reliable suppliers specializing in pharmaceutical and specialty intermediates ship globally, supporting research and preclinical production. Bulk purchases usually reflect economies of scale, letting large institutions or companies negotiate pricing and delivery that mesh with project demands. Careful sourcing—favoring suppliers who invest in third-party testing and open documentation—pays off in project pace and reliability.
Bringing in 4-Bromo-2,3-Difluorobenzoic Acid from reputable sources also means access to technical support, troubleshooting, and a wider knowledge base. It becomes more than a simple commodity, instead functioning as a critical building block in a collaborative, innovation-driven research process where each reagent’s performance affects not just a single project, but potentially a pipeline’s worth of scientific inquiry.
Trends in chemical synthesis point to growing sophistication—shorter routes, minimized waste, smarter designs. Multi-substituted benzoic acids like 4-Bromo-2,3-Difluorobenzoic Acid find themselves at the heart of efforts to improve selectivity and efficiency. Whether through green chemistry initiatives, embracing continuous flow systems, or integrating machine learning to choose better routes, the compounds enabling flexible, reliable transformations gain favor. From my own work tracking yield and efficiency data, a single robust intermediate multiplies options, supporting faster iteration cycles in both pharmaceutical and materials innovation.
A strong pipeline of new applications, from targeted cancer therapies to lightweight, durable electronics, draws on the kind of tailored reactivity that compounds like this deliver. Choosing 4-Bromo-2,3-Difluorobenzoic Acid is less about following a template and more about opening up possibility—bridging needs from bench science to industrial production, and from molecular design to real-world products that set new standards in their fields.